Literature DB >> 3762013

[IgG antibodies against toxic shock syndrome toxin 1 in human immunoglobulins].

N Dickgiesser, B Kustermann.   

Abstract

IgG antibodies against toxic shock syndrome toxin-1 in human immunoglobulins were determined using the ELISA technique. Of the drugs for intramuscular application, hemogamma and beriglobin contained the highest amount of antibodies. The highest concentration of antibodies in drugs for intravenous application was found in Pseudomonas polyglobin and in Venimmun.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3762013     DOI： 10.1007/bf01726914

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  7 in total

1.  Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1.

Authors:  J Parsonnet; J T Mills; Z A Gillis; G B Pier
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

2.  Biological properties of toxic shock syndrome exotoxin.

Authors:  P M Schlievert
Journal:  Surv Synth Pathol Res       Date:  1984

3.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

4.  Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

Authors:  J M Vergeront; S J Stolz; B A Crass; D B Nelson; J P Davis; M S Bergdoll
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

5.  Silver staining of proteins in polyacrylamide gels: increased sensitivity by a blue toning.

Authors:  G Berson
Journal:  Anal Biochem       Date:  1983-10-01       Impact factor: 3.365

6.  Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.

Authors:  N J Poindexter; P M Schlievert
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

7.  Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers.

Authors:  P F Bonventre; C Linnemann; L S Weckbach; J L Staneck; C R Buncher; E Vigdorth; H Ritz; D Archer; B Smith
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226
  7 in total
  3 in total

1.  [IgM antibodies to toxic shock syndrome toxin-1 in human sera and human immunoglobulins].

Authors:  N Dickgiesser; F Düzgün
Journal:  Klin Wochenschr       Date:  1988-01-04

2.  [IgG antibodies to toxic shock syndrome toxin-1 (TSST-1) in human sera].

Authors:  N Dickgiesser; B Kustermann
Journal:  Klin Wochenschr       Date:  1987-03-16

3.  Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.

Authors:  G Pilz; S Kääb; G Neeser; I Class; U Schweigart; A Brähler; O Bujdoso; R Neumann; K Werdan
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.